NanoViricides, Inc., a nano-biopharmaceutical research and development company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company develops Monkeypox Treatment for Monkeypox virus; Adenovirus 71 Treatment for severe pediatric hepatitis caused by Adenovirus 71 or related viruses; and HerpeCide Program Expansion Drug project that develops broad-spectrum nanoviricide drugs against different herpes viruses for different indications. The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of various types of Dengue viruses; and HIVCide, an escape-resistant anti-HIV nanoviricide. In addition, it develops other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. The company was founded in 2005 and is based in Shelton, Connecticut.
What is the ticker symbol for NanoViricides Inc? What does NNVC stand for in stocks?
NNVC is the stock ticker symbol of NanoViricides Inc. Every public company that trades on a stock exchange gets a ticker symbol.
What is the market capital of NanoViricides Inc (NNVC)?
As of Fri Dec 20 2024, market cap of NanoViricides Inc is 21.52 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.
What is the fair value of NNVC stock?
You can check NNVC's fair value in chart for subscribers.
Is NanoViricides Inc a good stock to buy?
The fair value guage provides a quick view whether NNVC is over valued or under valued. Whether NanoViricides Inc is cheap or expensive depends on the assumptions which impact NanoViricides Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NNVC.
What is 5 year return on NanoViricides Inc's stock?
In the past 10 years, NanoViricides Inc has provided -0.304 (multiply by 100 for percentage) rate of return.